A Bartke
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A Bartke.
Journal of Endocrinology | 2014
Marina C. Muñoz; Valeria Burghi; Johanna G. Miquet; Jorge F. Giani; Ricardo D Banegas; Jorge E. Toblli; Yimin Fang; Feiya Wang; A Bartke; Fernando P. Dominici
The renin-angiotensin system (RAS) plays a crucial role in the regulation of physiological homeostasis and diseases such as hypertension, coronary artery disease, and chronic renal failure. In this cascade, the angiotensin-converting enzyme (ACE)/angiotensin II (Ang II)/AT1 receptor axis induces pathological effects, such as vasoconstriction, cell proliferation, and fibrosis, while the ACE2/Ang-(1-7)/Mas receptor axis is protective for end-organ damage. The altered function of the RAS could be a contributing factor to the cardiac and renal alterations induced by GH excess. To further explore this issue, we evaluated the consequences of chronic GH exposure on the in vivo levels of Ang II, Ang-(1-7), ACE, ACE2, and Mas receptor in the heart and the kidney of GH-transgenic mice (bovine GH (bGH) mice). At the age of 7-8 months, female bGH mice displayed increased systolic blood pressure (SBP), a high degree of both cardiac and renal fibrosis, as well as increased levels of markers of tubular and glomerular damage. Angiotensinogen abundance was increased in the liver and the heart of bGH mice, along with a concomitant increase in cardiac Ang II levels. Importantly, the levels of ACE2, Ang-(1-7), and Mas receptor were markedly decreased in both tissues. In addition, Ang-(1-7) administration reduced SBP to control values in GH-transgenic mice, indicating that the ACE2/Ang-(1-7)/Mas axis is involved in GH-mediated hypertension. The data indicate that the altered expression profile of the ACE2/Ang-(1-7)/Mas axis in the heart and the kidney of bGH mice could contribute to the increased incidence of hypertension, cardiovascular, and renal alterations observed in these animals.
Journal of Molecular Endocrinology | 2015
Carolina Soledad Martinez; Verónica Gabriela Piazza; María Eugenia Díaz; Ravneet K Boparai; Oge Arum; María Cecilia Ramírez; Lorena Gonzalez; Damasia Becú-Villalobos; A Bartke; Daniel Turyn; Johanna G. Miquet; Ana I. Sotelo
GH/STAT5 signaling is desensitized in the liver in adult transgenic mice overexpressing GH; however, these animals present greater body size. To assess whether the STAT5 pathway is active during the growth period in the liver in these animals, and how signaling modulators participate in this process, growing transgenic mice and normal siblings were evaluated. STAT5 does not respond to an acute GH-stimulus, but displays higher basal phosphorylation in the livers of growing GH-overexpressing mice. GH receptor and the positive modulators glucocorticoid receptor and HNF1 display greater abundance in transgenic animals, supporting the activity of STAT5. The negative modulators cytokine-induced suppressor and PTP1B are increased in GH-overexpressing mice. The suppressors SOCS2 and SOCS3 exhibit higher mRNA levels in transgenic mice but lower protein content, indicating that they are being actively degraded. Therefore, STAT5 signaling is increased in the liver in GH-transgenic mice during the growth period, with a balance between positive and negative effectors resulting in accelerated but controlled growth.
Journal of Endocrinology | 2002
Fernando P. Dominici; S Hauck; Dp Argentino; A Bartke; D. Turyn
Journal of Endocrinology | 1999
Fernando P. Dominici; D Cifone; A Bartke; D. Turyn
Journal of Endocrinology | 1998
Fernando P. Dominici; A Balbis; A Bartke; D. Turyn
American Journal of Physiology-endocrinology and Metabolism | 1997
Daniel Turyn; Fernando P. Dominici; Ana I. Sotelo; A Bartke
Journal of Endocrinology | 2005
Johanna G. Miquet; A I Sotelo; Fernando P. Dominici; Michael S. Bonkowski; A Bartke; D. Turyn
Aging (Albany NY) | 2016
María Eugenia Matzkin; Johanna G. Miquet; Yimin Fang; Cristal M. Hill; Daniel Turyn; Ricardo S. Calandra; A Bartke; Monica B. Frungieri
Journal of Endocrinology | 2005
Johanna G. Miquet; A I Sotelo; A Bartke; D. Turyn
Journal of Endocrinology | 1999
Lorena Gonzalez; A I Sotelo; A Bartke; D. Turyn